There is a slide on pg 11 of the annual report depicting treatment of metastatic melanoma on forearm using TT as monotherapy and where keytruda had already been used for treatment
Previous treatment - keytruda 9 week washout prior to TT dosing
Complete response - Achieved by day 30 in in 3 injected and 4th non injected tumours (possible abscopal/ bystander effect)
No adverse effects reported, or additional treatment, wound intervention required.
Reason enough to be 'enthusiastic'
- Forums
- ASX - By Stock
- Qbiotics
Qbiotics, page-103
-
- There are more pages in this discussion • 1,154 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online